Oral ganciclovir for cytomegalovirus infections.
Follansbee
S E
SE
HIV Institute for Research and Treatment, Davies Medical Center, San Francisco, California, USA.
Stempien
M J
MJ
Buhles
W C
WC
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy; D015774:Ganciclovir / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans
D000998:Antiviral Agents; D015774:Ganciclovir